The Goldman Sachs Group, Inc. : Anticipation of a technical correction
Published on 01/02/2019 at 15:11
| Entry price | Target | Stop-loss | Potential |
|---|
|
US$198.26 |
US$190.5 |
US$204.1 |
+3.91% |
|---|
The chart of shares in Goldman Sachs Group suggests a correction over the short term. The timing to benefit from a likely reversal appears good.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases.
● Historically, the company has been releasing figures that are above expectations.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Stock prices approach a strong long-term resistance in weekly data at USD 207.19.
● According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the last four months, EPS estimates made by Thomson-Reuters analysts have been revised downwards.
● Below the resistance at 207.19 USD, the stock shows a negative configuration when looking looking at the weekly chart.
© MarketScreener.com - 2019
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener UK. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
